发明名称 |
Treatment of huntington'S disease |
摘要 |
The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection. |
申请公布号 |
US9408865(B2) |
申请公布日期 |
2016.08.09 |
申请号 |
US201414539305 |
申请日期 |
2014.11.12 |
申请人 |
Genix Therapeutics Group, LLC |
发明人 |
El-Rashidy Ragab |
分类号 |
A61K38/43;A61K31/714;A61K31/7076;A61K31/675;A61K31/455;A61K9/00;A61K9/19;A61K31/51 |
主分类号 |
A61K38/43 |
代理机构 |
Olson & Cepuritis, Ltd. |
代理人 |
Olson & Cepuritis, Ltd. |
主权项 |
1. A method for ameliorating loss of grip strength in a patient suffering from Huntington's Disease which comprises administering to the patient an effective amount of a composition comprising adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier, wherein the administration is by intramuscular injection, and wherein the effective amount administered comprises about 10-50 parts by weight adenosine triphosphate, about 50-250 parts by weight co-carboxylase, about 20-100 parts by weight nicotinamide, and about 0.5-1 parts by weight cyanocobalamin. |
地址 |
Skokie IL US |